Envista (NYSE:NVST – Free Report) had its price target hoisted by Evercore ISI from $18.00 to $23.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has an outperform rating on the stock.
A number of other equities research analysts also recently commented on the company. Needham & Company LLC reaffirmed a hold rating on shares of Envista in a research report on Thursday, August 8th. Stifel Nicolaus lowered their price target on Envista from $20.00 to $18.00 and set a buy rating for the company in a report on Tuesday, July 30th. JPMorgan Chase & Co. lowered shares of Envista from an overweight rating to a neutral rating and cut their price objective for the stock from $23.00 to $16.00 in a report on Thursday, August 8th. Robert W. Baird lowered their target price on shares of Envista from $19.00 to $17.00 and set a neutral rating for the company in a report on Monday, July 22nd. Finally, Piper Sandler cut their price target on shares of Envista from $18.00 to $16.00 and set a neutral rating on the stock in a research note on Tuesday, July 30th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of Hold and an average price target of $19.59.
Get Our Latest Stock Analysis on Envista
Envista Stock Up 3.2 %
Envista (NYSE:NVST – Get Free Report) last released its earnings results on Wednesday, August 7th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.16). Envista had a negative net margin of 52.25% and a positive return on equity of 4.86%. The firm had revenue of $633.10 million during the quarter, compared to analysts’ expectations of $646.88 million. During the same quarter last year, the company posted $0.43 earnings per share. Envista’s revenue for the quarter was down 4.4% on a year-over-year basis. Equities analysts anticipate that Envista will post 0.69 EPS for the current fiscal year.
Insider Transactions at Envista
In related news, CFO Eric D. Hammes bought 24,532 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The shares were acquired at an average cost of $16.33 per share, for a total transaction of $400,607.56. Following the acquisition, the chief financial officer now owns 24,532 shares in the company, valued at approximately $400,607.56. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.30% of the company’s stock.
Institutional Investors Weigh In On Envista
Several hedge funds and other institutional investors have recently added to or reduced their stakes in NVST. Creative Planning boosted its position in Envista by 116.5% in the 2nd quarter. Creative Planning now owns 24,246 shares of the company’s stock valued at $403,000 after buying an additional 13,047 shares during the last quarter. Algert Global LLC lifted its stake in shares of Envista by 132.4% in the second quarter. Algert Global LLC now owns 64,258 shares of the company’s stock worth $1,069,000 after acquiring an additional 36,608 shares in the last quarter. Scientech Research LLC boosted its holdings in Envista by 28.7% in the second quarter. Scientech Research LLC now owns 32,611 shares of the company’s stock valued at $542,000 after purchasing an additional 7,267 shares during the last quarter. AQR Capital Management LLC grew its stake in Envista by 45.2% during the 2nd quarter. AQR Capital Management LLC now owns 1,474,064 shares of the company’s stock valued at $24,484,000 after purchasing an additional 459,167 shares in the last quarter. Finally, Ariel Investments LLC increased its holdings in Envista by 11.0% during the 2nd quarter. Ariel Investments LLC now owns 9,871,152 shares of the company’s stock worth $164,157,000 after purchasing an additional 978,952 shares during the last quarter.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories
- Five stocks we like better than Envista
- Airline Stocks – Top Airline Stocks to Buy Now
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.